RS51402B - Imunostimulatorne kombinacije za profilaksu i lečenje hepatitisa c - Google Patents
Imunostimulatorne kombinacije za profilaksu i lečenje hepatitisa cInfo
- Publication number
- RS51402B RS51402B RSP-2010/0373A RSP20100373A RS51402B RS 51402 B RS51402 B RS 51402B RS P20100373 A RSP20100373 A RS P20100373A RS 51402 B RS51402 B RS 51402B
- Authority
- RS
- Serbia
- Prior art keywords
- hepatitis
- treatment
- immunostimulatory
- combinaton
- prophylactics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Imunostimulatorna kombinacija za profilaksu i lečenje hepatitisa C, naznačena time štosadrži:a) Poli(I:C) koji deluje kao agonist TLR3,b) agonist CD40 ili sekvenca DNK koja ga kodira, ic) polipeptid, koji sadrži NS3 protein virusa hepatitisa C, ili fragment navedenog NS3 proteina sa kapacitetom za indukciju CD8+ i CD4+ odgovora.Prijava sadrži još 17 zavisnih patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502446 | 2005-10-07 | ||
ES200601563A ES2334472B1 (es) | 2006-06-09 | 2006-06-09 | Combinacion inmunoestimuladora para profilaxis y tratamiento de hepatitis c. |
Publications (1)
Publication Number | Publication Date |
---|---|
RS51402B true RS51402B (sr) | 2011-02-28 |
Family
ID=37942331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2010/0373A RS51402B (sr) | 2005-10-07 | 2006-10-05 | Imunostimulatorne kombinacije za profilaksu i lečenje hepatitisa c |
Country Status (19)
Country | Link |
---|---|
US (2) | US20100047231A1 (sr) |
EP (1) | EP1949913B1 (sr) |
JP (1) | JP2009511452A (sr) |
CN (1) | CN101330928B (sr) |
AT (1) | ATE469657T1 (sr) |
AU (1) | AU2006301171B9 (sr) |
BR (1) | BRPI0616978A2 (sr) |
CA (1) | CA2625506C (sr) |
CY (1) | CY1110744T1 (sr) |
DE (1) | DE602006014720D1 (sr) |
DK (1) | DK1949913T3 (sr) |
ES (1) | ES2346570T3 (sr) |
HR (1) | HRP20100473T1 (sr) |
PL (1) | PL1949913T3 (sr) |
PT (1) | PT1949913E (sr) |
RS (1) | RS51402B (sr) |
RU (1) | RU2431499C2 (sr) |
SI (1) | SI1949913T1 (sr) |
WO (1) | WO2007042583A1 (sr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2066339B1 (en) | 2006-09-18 | 2014-08-13 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses |
AU2008318615A1 (en) * | 2007-10-30 | 2009-05-07 | Texas A&M University System | Compositions and methods of enhancing immune responses to flagellated bacterium |
HUE047164T2 (hu) | 2007-11-01 | 2020-04-28 | Univ Arkansas | Kompozíciók és eljárások eimeria elleni immunválasz fokozására |
MX2011005915A (es) | 2008-12-03 | 2011-08-17 | Proyecto Biomedicina Cima Sl | Uso de modulinas solubles en fenol para el desarrollo de vacunas. |
ES2635080T3 (es) * | 2009-03-10 | 2017-10-02 | Baylor Research Institute | Vacunas contra el cáncer dirigidas a células presentadoras de antígenos |
CA2787661C (en) | 2010-01-21 | 2021-10-12 | The Board Of Trustees Of The University Of Arkansas | Vaccine vectors and methods of enhancing immune responses |
EP3556397A1 (en) | 2010-06-09 | 2019-10-23 | The Board of Trustees of the University of Arkansas | Vaccine and methods to reduce campylobacter infection |
PL2956165T3 (pl) | 2013-02-14 | 2020-04-30 | The Board Of Trustees Of The University Of Arkansas | Kompozycje i sposoby wzmacniania odpowiedzi immunologicznych na Eimeria lub ograniczania infekcji Eimeria |
EA033538B1 (ru) | 2013-03-15 | 2019-10-31 | Univ Arkansas | Композиции и способы усиления иммунного ответа на кишечные патогены |
US10682398B2 (en) | 2016-05-03 | 2020-06-16 | The Texas A&M University System | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049390A (en) * | 1987-09-02 | 1991-09-17 | Allergy Immuno Technologies, Inc. | Liposome containing immunotherapy agents for treating IgE mediated allergies |
CN1325517C (zh) * | 1998-07-21 | 2007-07-11 | 展马博联合股份有限公司 | 抗丙型肝炎病毒抗体及其用途 |
US7022830B2 (en) * | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
ATE517184T1 (de) * | 2000-08-17 | 2011-08-15 | Tripep Ab | Hcv ns3/4a kodierende nukleinsäure |
EP2258712A3 (en) * | 2002-03-15 | 2011-05-04 | Multicell Immunotherapeutics, Inc. | Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs |
CA2511538C (en) * | 2002-12-30 | 2013-11-26 | 3M Innovative Properties Company | Immunostimulatory combinations |
-
2006
- 2006-10-05 BR BRPI0616978-3A patent/BRPI0616978A2/pt not_active IP Right Cessation
- 2006-10-05 RU RU2008117328/15A patent/RU2431499C2/ru not_active IP Right Cessation
- 2006-10-05 RS RSP-2010/0373A patent/RS51402B/sr unknown
- 2006-10-05 DE DE602006014720T patent/DE602006014720D1/de active Active
- 2006-10-05 JP JP2008534032A patent/JP2009511452A/ja active Pending
- 2006-10-05 CN CN2006800457078A patent/CN101330928B/zh not_active Expired - Fee Related
- 2006-10-05 ES ES06830863T patent/ES2346570T3/es active Active
- 2006-10-05 US US12/083,217 patent/US20100047231A1/en not_active Abandoned
- 2006-10-05 AU AU2006301171A patent/AU2006301171B9/en not_active Ceased
- 2006-10-05 SI SI200630732T patent/SI1949913T1/sl unknown
- 2006-10-05 CA CA2625506A patent/CA2625506C/en not_active Expired - Fee Related
- 2006-10-05 PT PT06830863T patent/PT1949913E/pt unknown
- 2006-10-05 PL PL06830863T patent/PL1949913T3/pl unknown
- 2006-10-05 AT AT06830863T patent/ATE469657T1/de active
- 2006-10-05 EP EP06830863A patent/EP1949913B1/en active Active
- 2006-10-05 DK DK06830863.4T patent/DK1949913T3/da active
- 2006-10-05 WO PCT/ES2006/000554 patent/WO2007042583A1/es active Application Filing
-
2010
- 2010-08-19 CY CY20101100769T patent/CY1110744T1/el unknown
- 2010-08-30 HR HR20100473T patent/HRP20100473T1/hr unknown
-
2013
- 2013-09-27 US US14/039,269 patent/US20140056943A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2009511452A (ja) | 2009-03-19 |
RU2431499C2 (ru) | 2011-10-20 |
WO2007042583A1 (es) | 2007-04-19 |
DK1949913T3 (da) | 2010-10-04 |
CY1110744T1 (el) | 2015-06-10 |
ATE469657T1 (de) | 2010-06-15 |
SI1949913T1 (sl) | 2011-02-28 |
CA2625506C (en) | 2014-06-10 |
AU2006301171A1 (en) | 2007-04-19 |
ES2346570T3 (es) | 2010-10-18 |
RU2008117328A (ru) | 2009-11-20 |
BRPI0616978A2 (pt) | 2011-07-05 |
US20100047231A1 (en) | 2010-02-25 |
PT1949913E (pt) | 2010-08-24 |
EP1949913A1 (en) | 2008-07-30 |
US20140056943A1 (en) | 2014-02-27 |
AU2006301171B9 (en) | 2012-03-29 |
PL1949913T3 (pl) | 2010-10-29 |
DE602006014720D1 (de) | 2010-07-15 |
CN101330928A (zh) | 2008-12-24 |
CA2625506A1 (en) | 2007-04-19 |
CN101330928B (zh) | 2012-11-14 |
EP1949913B1 (en) | 2010-06-02 |
AU2006301171B2 (en) | 2011-10-27 |
HRP20100473T1 (hr) | 2010-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS51402B (sr) | Imunostimulatorne kombinacije za profilaksu i lečenje hepatitisa c | |
ECSP045191A (es) | "nuevos péptidos como inhibidores de la proteasa serina ns3 del virus de la hepatitis c" | |
ECSP034438A (es) | Nuevos peptidos como inhibidores de ns-3-serina proteasa del virus de la hepatitis c | |
EA200600498A1 (ru) | Макроциклические пептиды, проявляющие противовирусную активность в отношении вируса гепатита с | |
CL2011002453A1 (es) | Compuestos derivados de diazol u oxazol-pirrol o pirrolciclopropil condensados sustituidos, inhibidores de la función de la proteína ns5a codificada por el virus de la hepatitis c (vhc); composición farmacéutica; y su uso para el tratamiento de una infección por vhc. | |
ATE426412T1 (de) | Adjuvante influenza-vakzine | |
ECSP066495A (es) | Composiciones y metodos para inhibir la infección por virus de síndrome de punto blanco (wssv) | |
BRPI0508217A (pt) | cetamidas com p4's cìclico como inibidores de ns3 serina protease de vìrus de hepatite c | |
CL2011002426A1 (es) | Compuestos derivados de benzo-diazol pirrolidina sustituidos, inhibidores de la funcion de la proteina ns5a codificada por el virus de la hepatitis c (vhc); composicion farmaceutica; y su uso para el tratamiento de una infeccion por vhc. | |
ATE474827T1 (de) | Hcv-replikationshemmer | |
TWI265927B (en) | Novel compounds as NS3-serine protease inhibitors of hepatitis C virus | |
CY1112924T1 (el) | Κυτταροδιαπερατοι αναστολεις της jnk-σηματοδοτικης πορειας μεταγωγης | |
TW200602037A (en) | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease | |
DK1556021T3 (da) | Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger | |
TW200740458A (en) | Vaccination against dengue virus infection | |
IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
TNSN07150A1 (en) | Semi-soft c-class immunostimulatory oligonucleotides | |
EA201001322A1 (ru) | Вакцины против хламидиоза | |
MX2011006846A (es) | Virus de fiebre porcina clasico recombinante (csfv) comprendiendo una proteina e2 modificada y metodos para generar dicho csfv. | |
CY1110980T1 (el) | Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες | |
BR0316346A (pt) | Vacina para vìrus do nilo ocidental | |
MXPA06013388A (es) | Vector lentiviral recombinante para la expresion de una proteina flaviviridae y sus aplicaciones como vacuna. | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
DE60316821D1 (de) | Aminobenzothiazolverbindungen mit nos-hemmender wirkung | |
TW200502246A (en) | Vaccine |